Cargando…
Cancer dormancy: time to explore its clinical relevance
Dormant disseminated cancer cells, arrested and nonproliferating, are “good” cancer cells because there is no need to worry unless they resume growth. The mechanisms by which dormant disseminated cancer cells are put to sleep at distant sites and re-awakened are poorly understood. Moreover, it is no...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979111/ https://www.ncbi.nlm.nih.gov/pubmed/24359585 http://dx.doi.org/10.1186/bcr3590 |
_version_ | 1782310689243660288 |
---|---|
author | Gužvić, Miodrag Klein, Christoph A |
author_facet | Gužvić, Miodrag Klein, Christoph A |
author_sort | Gužvić, Miodrag |
collection | PubMed |
description | Dormant disseminated cancer cells, arrested and nonproliferating, are “good” cancer cells because there is no need to worry unless they resume growth. The mechanisms by which dormant disseminated cancer cells are put to sleep at distant sites and re-awakened are poorly understood. Moreover, it is not clear whether re-awakened cancer cells have a role in disease courses. Cyrus Ghajar and colleagues identified a mechanism of dormancy and growth resumption that might become important when more closely linked to clinical reality. |
format | Online Article Text |
id | pubmed-3979111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39791112014-06-20 Cancer dormancy: time to explore its clinical relevance Gužvić, Miodrag Klein, Christoph A Breast Cancer Res Viewpoint Dormant disseminated cancer cells, arrested and nonproliferating, are “good” cancer cells because there is no need to worry unless they resume growth. The mechanisms by which dormant disseminated cancer cells are put to sleep at distant sites and re-awakened are poorly understood. Moreover, it is not clear whether re-awakened cancer cells have a role in disease courses. Cyrus Ghajar and colleagues identified a mechanism of dormancy and growth resumption that might become important when more closely linked to clinical reality. BioMed Central 2013 2013-12-20 /pmc/articles/PMC3979111/ /pubmed/24359585 http://dx.doi.org/10.1186/bcr3590 Text en Copyright © 2013 BioMed Central Ltd. |
spellingShingle | Viewpoint Gužvić, Miodrag Klein, Christoph A Cancer dormancy: time to explore its clinical relevance |
title | Cancer dormancy: time to explore its clinical relevance |
title_full | Cancer dormancy: time to explore its clinical relevance |
title_fullStr | Cancer dormancy: time to explore its clinical relevance |
title_full_unstemmed | Cancer dormancy: time to explore its clinical relevance |
title_short | Cancer dormancy: time to explore its clinical relevance |
title_sort | cancer dormancy: time to explore its clinical relevance |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979111/ https://www.ncbi.nlm.nih.gov/pubmed/24359585 http://dx.doi.org/10.1186/bcr3590 |
work_keys_str_mv | AT guzvicmiodrag cancerdormancytimetoexploreitsclinicalrelevance AT kleinchristopha cancerdormancytimetoexploreitsclinicalrelevance |